13D/13G Filings - ARROWHEAD PHARMACEUTICALS INC. (ARWR)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-08-15
5:28 pm
Sale
2025-08-1313DArrowhead Pharmaceuticals, Inc.
ARWR
Sarepta Therapeutics Inc.
SRPT
0
0.000%
-11,926,301decrease
(Position Closed)
Filing
History
2025-08-14
07:07 am
Sale
2025-06-3013GArrowhead Pharmaceuticals, Inc.
ARWR
Avoro Capital Advisors LLC11,517,441
8.300%
-511,111decrease
(-4.25%)
Filing
History
2025-08-11
07:01 am
Sale
2025-06-3013GArrowhead Pharmaceuticals, Inc.
ARWR
STATE STREET CORP
STT
6,371,056
4.600%
-628,193decrease
(-8.98%)
Filing
History
2025-07-29
11:20 am
Purchase
2025-06-3013GArrowhead Pharmaceuticals, Inc.
ARWR
VANGUARD GROUP INC15,525,072
11.240%
3,121,022increase
(+25.16%)
Filing
History
2025-05-13
10:26 am
Purchase
2025-03-3113GArrowhead Pharmaceuticals, Inc.
ARWR
STATE STREET CORP
STT
6,999,249
5.100%
983,022increase
(+16.34%)
Filing
History
2025-04-23
8:14 pm
Purchase
2025-03-3113GArrowhead Pharmaceuticals, Inc.
ARWR
BlackRock Inc.
BLK
19,012,855
13.800%
5,709,574increase
(+42.92%)
Filing
History
2025-02-14
5:23 pm
Purchase
2025-02-0713DArrowhead Pharmaceuticals, Inc.
ARWR
Sarepta Therapeutics Inc.
SRPT
11,926,301
9.500%
11,926,301increase
(New Position)
Filing
History
2025-02-14
09:31 am
Purchase
2024-12-3113GArrowhead Pharmaceuticals, Inc.
ARWR
Avoro Capital Advisors LLC12,028,552
9.600%
3,139,664increase
(+35.32%)
Filing
History
2025-02-05
06:41 am
Sale
2024-12-3113GArrowhead Pharmaceuticals, Inc.
ARWR
STATE STREET CORP
STT
6,016,227
4.800%
-338,104decrease
(-5.32%)
Filing
History
2024-11-14
09:38 am
Purchase
2024-09-3013GArrowhead Pharmaceuticals, Inc.
ARWR
Avoro Capital Advisors LLC8,888,888
7.200%
8,888,888increase
(New Position)
Filing
History
2024-10-16
09:15 am
Sale
2024-09-3013GArrowhead Pharmaceuticals, Inc.
ARWR
STATE STREET CORP
STT
6,354,331
5.100%
-470,780decrease
(-6.90%)
Filing
History
2024-04-10
2:03 pm
Purchase
2024-03-2813GArrowhead Pharmaceuticals, Inc.
ARWR
VANGUARD GROUP INC12,404,050
10.010%
1,731,974increase
(+16.23%)
Filing
History
2024-02-13
4:58 pm
Sale
2023-12-2913GArrowhead Pharmaceuticals, Inc.
ARWR
VANGUARD GROUP INC10,672,076
9.930%
-158,357decrease
(-1.46%)
Filing
History
2024-01-24
12:57 pm
Purchase
2023-12-3113GArrowhead Pharmaceuticals, Inc.
ARWR
STATE STREET CORP
STT
6,825,111
6.350%
854,767increase
(+14.32%)
Filing
History
2024-01-23
4:14 pm
Purchase
2023-12-3113GArrowhead Pharmaceuticals, Inc.
ARWR
BlackRock Inc.
BLK
13,303,281
12.400%
592,650increase
(+4.66%)
Filing
History
2023-06-09
2:15 pm
Purchase
2023-05-3113GArrowhead Pharmaceuticals, Inc.
ARWR
VANGUARD GROUP INC10,830,433
10.130%
544,261increase
(+5.29%)
Filing
History
2023-02-09
11:07 am
Purchase
2022-12-3013GArrowhead Pharmaceuticals, Inc.
ARWR
VANGUARD GROUP INC10,286,172
9.700%
646,029increase
(+6.70%)
Filing
History
2023-02-08
10:08 am
Purchase
2022-12-3113GArrowhead Pharmaceuticals, Inc.
ARWR
STATE STREET CORP
STT
5,970,344
5.630%
1,845,874increase
(+44.75%)
Filing
History
2023-01-26
08:52 am
Unchanged
2022-12-3113GArrowhead Pharmaceuticals, Inc.
ARWR
BlackRock Inc.
BLK
12,710,631
12.000%
0
(Unchanged)
Filing
History
2023-01-20
09:43 am
Purchase
2022-12-3113GArrowhead Pharmaceuticals, Inc.
ARWR
BlackRock Inc.
BLK
12,710,631
12.000%
702,568increase
(+5.85%)
Filing
History
Goto 0, 1, Next